论文部分内容阅读
目的分析阿卡波糖联合二甲双胍治疗初发2型糖尿病伴高脂血症的效果。方法回顾性分析2012年1月至2014年12月郑州市第三人民医院诊治的120例初发2型糖尿病伴高脂血症患者的临床资料,按照不同治疗方式分为两组,每组60例。对照组予阿卡波糖治疗,研究组予阿卡波糖联合二甲双胍治疗,对比两组血糖、血脂指标改善情况及用药不良反应发生率。结果两组治疗后血糖、血脂指标均较治疗前发生显著改善,但是研究组改善幅度优于对照组(P<0.05)。结论阿卡波糖联合二甲双胍治疗初发2型糖尿病伴高脂血症的效果显著。
Objective To analyze the effect of acarbose combined with metformin in the treatment of newly diagnosed type 2 diabetes with hyperlipidemia. Methods The clinical data of 120 patients with newly diagnosed type 2 diabetes mellitus and hyperlipidemia diagnosed and treated by the Third People’s Hospital of Zhengzhou City from January 2012 to December 2014 were retrospectively analyzed. According to the different treatment methods, the data were divided into two groups of 60 example. The control group was treated with acarbose, and the study group was treated with acarbose and metformin. The improvement of blood glucose and blood lipid and the incidence of adverse reactions were compared between the two groups. Results After treatment, the blood glucose and blood lipids were significantly improved in both groups, but the improvement rate in the study group was better than that in the control group (P <0.05). Conclusion Acarbose combined with metformin in the treatment of newly diagnosed type 2 diabetes with hyperlipidemia was significantly effective.